Quercetin alleviates hyperoxia‐induced bronchopulmonary dysplasia by inhibiting ferroptosis through the MAPK / PTGS2 pathway: Insights from network pharmacology, molecular docking, and experimental evaluations
Chemical Biology & Drug Design · 2024
DOI: 10.1111/cbdd.14520 ↗At a glance
Journal article in Chemical Biology & Drug Design, 2024. Written by Xianhui Deng and 6 co-authors. Institution: Department of Neonatology, Affiliated Women's Hospital of Jiangnan University, Wuxi Maternity and Child Health Care Hospital, Wuxi, China. Major MEDLINE topics: Bronchopulmonary Dysplasia, Hyperoxia, Ferroptosis. Cited 13 times so far (Crossref); 31 references. Funded by: National Natural Science Foundation of China, Jiangsu Commission of Health and Family Planning, Medical Key Discipline Program of Wuxi Health Commission.
Abstract (original language)
Quercetin, a bioactive natural compound renowned for its potent anti‐inflammatory, antioxidant, and antiviral properties, has exhibited therapeutic potential in various diseases. Given that bronchopulmonary dysplasia (BPD) development is closely linked to inflammation and oxidative stress, and quercetin, a robust antioxidant known to activate NRF2 and influence the ferroptosis pathway, offers promise for a wide range of age groups. Nonetheless, the specific role of quercetin in BPD remains largely unexplored. This study aims to uncover the target role of quercetin in BPD through a combination of network pharmacology, molecular docking, computer analyses, and experimental evaluations.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Neonatology, Affiliated Women's Hospital of Jiangnan University, Wuxi Maternity and Child Health Care Hospital, Wuxi, China.
- Department of Physiopathology, Wuxi School of Medicine, Jiangnan University, Wuxi, China.
- Research Institute for Reproductive Health and Genetic Diseases, Affiliated Women's Hospital of Jiangnan University, Wuxi, China.
- Department of Pediatric, Wuxi Yihe Gynaecology and Obstetrics Hospital, Wuxi, China.
Funding
- National Natural Science Foundation of China
- Jiangsu Commission of Health and Family Planning
- Medical Key Discipline Program of Wuxi Health Commission
Cite
APA
Deng, X., Chen, D., Xie, A., Li, S., Chen, A., Zhou, Q., & Yu, R. (2024). Quercetin alleviates hyperoxia‐induced bronchopulmonary dysplasia by inhibiting ferroptosis through the MAPK / PTGS2 pathway: Insights from network pharmacology, molecular docking, and experimental evaluations. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14520
Vancouver
Deng X, Chen D, Xie A, Li S, Chen A, Zhou Q, et al. Quercetin alleviates hyperoxia‐induced bronchopulmonary dysplasia by inhibiting ferroptosis through the MAPK / PTGS2 pathway: Insights from network pharmacology, molecular docking, and experimental evaluations. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14520
BibTeX
@article{Deng2024,
author = {Deng, Xianhui and Chen, Dan and Xie, Anni and Li, Shengpeng and Chen, Ailing and Zhou, Qin and Yu, Renqiang},
title = {Quercetin alleviates hyperoxia‐induced bronchopulmonary dysplasia by inhibiting ferroptosis through the MAPK / PTGS2 pathway: Insights from network pharmacology, molecular docking, and experimental evaluations},
journal = {Chemical Biology & Drug Design},
year = {2024},
doi = {10.1111/cbdd.14520}
}
EUVIMED